Home › Grants › PA-26-001

Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)

Federal funding opportunity PA-26-001 from National Institutes of Health (Department of Health and Human Services).

Apply on Grants.gov →Application closes November 30, 2028

Program funding history

Synopsis

Who can apply

• Native American tribal organizations (other than Federally recognized tribal governments)
• Small businesses
• Native American tribal governments (Federally recognized)
• Private institutions of higher education
• Special district governments
• Others (see text field entitled "Additional Information on Eligibility" for clarification)
• Public housing authorities/Indian housing authorities
• County governments
• State governments
• Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
• Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
• City or township governments
• Public and State controlled institutions of higher education
• For profit organizations other than small businesses
• Independent school districts

Other Eligible Applicants: Indian/Native American Tribal Governments (Other than Federally Recognized); Eligible Agencies of the Federal Government; U.S. Territory or Possession; Faith-based or Community-based Organizations; Regional Organizations; Non-domestic (non-U.S.) Entities (Foreign Organizations). Reminder: This NOFO supports administrative supplements to existing projects. To be eligible, the parent award must be active (i.e., not in a co-cost extension), and the research proposed in the supplement must be accomplished within the competitive segment. The proposed supplement must be to provide for an increase in costs due to unforeseen circumstances. All additional costs must be within the scope of the peer reviewed and approved project. IMPORTANT: The research proposed in the supplement application must be within the peer-reviewed scope of the NIH-supported grant project. Foreign Organizations/International Collaborations: All activities with foreign institutions must align with existing parent award. NIH will no longer issue awards (new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. This new requirement was effective, May 1, 2025. Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding. This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or foreign components, funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors.

How to apply

Similar grants

• Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
  PAR-25-274 · National Institutes of Health · closes November 17, 2026
• Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)
  PAR-24-276 · National Institutes of Health · closes July 14, 2026
• Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
  PAR-25-268 · National Institutes of Health · closes November 17, 2026
• Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
  PAR-25-155 · National Institutes of Health · closes October 19, 2026
• Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
  PAR-25-144 · National Institutes of Health · closes January 7, 2028
• Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
  PAR-25-143 · National Institutes of Health · closes January 7, 2028